DK1309347T3 - Fremgangsmåde og sammensætning til ændring af en B-cellemedieret patologi - Google Patents

Fremgangsmåde og sammensætning til ændring af en B-cellemedieret patologi

Info

Publication number
DK1309347T3
DK1309347T3 DK01979228.2T DK01979228T DK1309347T3 DK 1309347 T3 DK1309347 T3 DK 1309347T3 DK 01979228 T DK01979228 T DK 01979228T DK 1309347 T3 DK1309347 T3 DK 1309347T3
Authority
DK
Denmark
Prior art keywords
altering
composition
cell mediated
mediated pathology
pathology
Prior art date
Application number
DK01979228.2T
Other languages
English (en)
Inventor
Robert J Shopes
Daniel P Gold
Original Assignee
Mmrglobal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mmrglobal Inc filed Critical Mmrglobal Inc
Application granted granted Critical
Publication of DK1309347T3 publication Critical patent/DK1309347T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK01979228.2T 2000-08-11 2001-08-10 Fremgangsmåde og sammensætning til ændring af en B-cellemedieret patologi DK1309347T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22472200P 2000-08-11 2000-08-11
US22472300P 2000-08-11 2000-08-11
US27907901P 2001-03-23 2001-03-23
PCT/US2001/025204 WO2002013862A2 (en) 2000-08-11 2001-08-10 Method and composition for altering a b cell mediated pathology

Publications (1)

Publication Number Publication Date
DK1309347T3 true DK1309347T3 (da) 2013-03-25

Family

ID=27397393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01979228.2T DK1309347T3 (da) 2000-08-11 2001-08-10 Fremgangsmåde og sammensætning til ændring af en B-cellemedieret patologi

Country Status (12)

Country Link
EP (1) EP1309347B1 (da)
JP (1) JP2004506022A (da)
KR (1) KR20030038693A (da)
CN (1) CN1273191C (da)
AU (2) AU2002211214B9 (da)
CA (1) CA2416898A1 (da)
DK (1) DK1309347T3 (da)
ES (1) ES2401421T3 (da)
HK (1) HK1052295B (da)
MX (1) MXPA03001141A (da)
SG (2) SG2010046837A (da)
WO (1) WO2002013862A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1551444B1 (en) 2002-10-16 2018-03-21 Samuel F. Hunter Method for treatment of demyelinating central nervous system disease using gm-csf
CA2539432A1 (en) * 2003-09-23 2005-04-07 Favrille, Inc. Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
US20070160994A1 (en) * 2003-12-15 2007-07-12 Institut Pasteur Repertoire determination of a lymphocyte b population
ATE421998T1 (de) * 2003-12-15 2009-02-15 Pasteur Institut Ermittlung des repertoires von b-lymphozyten populationen
US8143007B2 (en) * 2008-03-13 2012-03-27 National Institute Of Immunology Nested primer sets for amplifying mouse immunoglobulin variable gene segments
US9399670B2 (en) 2009-02-20 2016-07-26 Hoffmann-La Roche Inc. Method for obtaining immunoglobulin encoding nucleic acid
KR20140064857A (ko) 2011-09-21 2014-05-28 에프. 호프만-라 로슈 아게 TaqMan 프로브와 조합된 다중 PCR 에 의해 단일 항체 생성 세포로부터 FAB 단편을 수득하는 방법
US10745468B2 (en) 2011-12-22 2020-08-18 Kota Biotherapeutics, Llc Compositions and methods for modified B cells expressing reassigned biological agents
MX2017011322A (es) * 2015-03-05 2017-12-07 Boehringer Ingelheim Vetmedica Inc Sistema de marcadores, en particular para antigenos subunitarios expresados por baculovirus.
CN105925610B (zh) * 2016-05-19 2019-12-06 武汉金开瑞生物工程有限公司 昆虫杆状病毒表达载体、构建方法及其应用
WO2017214376A1 (en) * 2016-06-10 2017-12-14 Elwha Llc Compositions and methods including b lymphocyte cell line expressing membrane immunoglobulin different from secreted immunoglobulin and cytolytic function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816249A (en) * 1981-11-17 1989-03-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies
IL126121A0 (en) * 1996-05-01 1999-05-09 Genitope Corp Vaccines for treatment of lymphoma and leukemia
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods

Also Published As

Publication number Publication date
HK1052295B (zh) 2013-06-21
KR20030038693A (ko) 2003-05-16
HK1052295A1 (en) 2003-09-11
AU1121402A (en) 2002-02-25
EP1309347B1 (en) 2013-02-27
WO2002013862A3 (en) 2002-12-05
MXPA03001141A (es) 2004-10-04
WO2002013862A2 (en) 2002-02-21
AU2002211214B2 (en) 2005-07-21
CN1468123A (zh) 2004-01-14
CA2416898A1 (en) 2002-02-21
CN1273191C (zh) 2006-09-06
EP1309347A2 (en) 2003-05-14
JP2004506022A (ja) 2004-02-26
SG2010046837A (en) 2017-02-27
AU2002211214B9 (en) 2005-10-06
ES2401421T3 (es) 2013-04-19
SG128482A1 (en) 2007-01-30

Similar Documents

Publication Publication Date Title
DK1276551T3 (da) Kompositmembran og fremgangsmåde til fremstilling af samme
DK1610708T3 (da) Fremgangsmåde og system til fabrikation af en tandkappe
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1339292T3 (da) Sammensætning og fremgangsmåde
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1153561T3 (da) Indretning til udtrækning af en substans
DK1295509T3 (da) Fremgangsmåde til fremstilling af en otoplastik og en tilsvarende otoplastik
AR028110A1 (es) Nuevo proceso
DK1550535T3 (da) Fremgangsmåde og indretning til fremstilling af betonmasse
DE60125853D1 (de) Bildherstellungsverfahren
DK1325100T3 (da) Sammensætninger og fremgangsmåder til rensning af kontaktlinser
DK1263745T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiaxol-2-oner og anvendelse deraf til inhibering af hormonfölsom lipase
DK1285199T3 (da) Apparat til behandling af affald
DK1309347T3 (da) Fremgangsmåde og sammensætning til ændring af en B-cellemedieret patologi
FR2816882B1 (fr) Reliure et procedes pour sa fabrication
DK1345944T3 (da) Fremgangsmåde til isolering og oprensning af epothiloner
DE60130173D1 (de) Kamerakalibrierungsverfahren
DK1253248T3 (da) Rengöringsmaskine og fremgangsmåde til rengöring af ballast
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1197257T3 (da) Fremgangsmåde og indretning til tilvejebringelse af varme arbejdsgasser
DK1128447T3 (da) Superledende tråd og fremgangsmåde til fremstilling af samme
DK1300160T3 (da) Fremgangsmåde til stabilisering af en sammensætning
DK1216965T3 (da) Fremgangsmåde og indretning til afköling af deflektorslidsker
DK1316239T3 (da) Höreapparat og fremgangsmåde til fremstilling af samme
FI20002695A0 (fi) Suodatusmenetelmä